Literature DB >> 19630789

Fibrinogen signal transduction in the nervous system.

J K Ryu1, D Davalos, K Akassoglou.   

Abstract

Fibrinogen is a pleiotropic blood protein that regulates coagulation, inflammation and tissue repair. Fibrinogen extravasates in the nervous system after injury or disease associated with vascular damage or blood-brain barrier (BBB) disruption. Fibrinogen is not merely a marker of BBB disruption, but plays a causative role in neurologic disease as a potent inducer of inflammation and an inhibitor of neurite outgrowth. Fibrinogen mediates functions in the nervous system as a ligand for cell-specific receptors. In microglia, fibrinogen mediates activation of Akt and Rho via the CD11b/CD18 integrin receptor, while in neurons fibrinogen induces phosphorylation of epidermal growth factor (EGF) receptor via the alphavbeta3 integrin. Pharmacologic targeting of the interactions of fibrinogen with its nervous system receptors could provide novel strategies for therapeutic intervention in neuroinflammatory and neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19630789      PMCID: PMC2888044          DOI: 10.1111/j.1538-7836.2009.03438.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  30 in total

Review 1.  Astrocyte-endothelial interactions at the blood-brain barrier.

Authors:  N Joan Abbott; Lars Rönnbäck; Elisabeth Hansson
Journal:  Nat Rev Neurosci       Date:  2006-01       Impact factor: 34.870

2.  Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity?

Authors:  Christina Marik; Paul A Felts; Jan Bauer; Hans Lassmann; Kenneth J Smith
Journal:  Brain       Date:  2007-11       Impact factor: 13.501

3.  Bench to bedside: tempering antigen-presenting cells in multiple sclerosis.

Authors:  Thomas Prod'homme; Scott S Zamvil
Journal:  Nat Med       Date:  2008-06       Impact factor: 53.440

4.  Cerebral ischemia-hypoxia induces intravascular coagulation and autophagy.

Authors:  Faisal Adhami; Guanghong Liao; Yury M Morozov; Aryn Schloemer; Vincent J Schmithorst; John N Lorenz; R Scott Dunn; Charles V Vorhees; Marsha Wills-Karp; Jay L Degen; Roger J Davis; Noboru Mizushima; Pasko Rakic; Bernard J Dardzinski; Scott K Holland; Frank R Sharp; Chia-Yi Kuan
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

5.  Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets.

Authors:  May H Han; Sun-Il Hwang; Dolly B Roy; Deborah H Lundgren; Jordan V Price; Shalina S Ousman; Guy Haskin Fernald; Bruce Gerlitz; William H Robinson; Sergio E Baranzini; Brian W Grinnell; Cedric S Raine; Raymond A Sobel; David K Han; Lawrence Steinman
Journal:  Nature       Date:  2008-02-17       Impact factor: 49.962

Review 6.  Fibrinogen signal transduction as a mediator and therapeutic target in inflammation: lessons from multiple sclerosis.

Authors:  R A Adams; C Schachtrup; D Davalos; I Tsigelny; K Akassoglou
Journal:  Curr Med Chem       Date:  2007       Impact factor: 4.530

7.  Fibrin(ogen) exacerbates inflammatory joint disease through a mechanism linked to the integrin alphaMbeta2 binding motif.

Authors:  Matthew J Flick; Christine M LaJeunesse; Kathryn E Talmage; David P Witte; Joseph S Palumbo; Malinda D Pinkerton; Sherry Thornton; Jay L Degen
Journal:  J Clin Invest       Date:  2007-11       Impact factor: 14.808

8.  Fibrinogen inhibits neurite outgrowth via beta 3 integrin-mediated phosphorylation of the EGF receptor.

Authors:  Christian Schachtrup; Paul Lu; Leonard L Jones; Jae K Lee; Jerry Lu; Ben D Sachs; Binhai Zheng; Katerina Akassoglou
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-02       Impact factor: 11.205

9.  Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer's disease.

Authors:  Justin Paul; Sidney Strickland; Jerry P Melchor
Journal:  J Exp Med       Date:  2007-07-30       Impact factor: 14.307

10.  A leaky blood-brain barrier, fibrinogen infiltration and microglial reactivity in inflamed Alzheimer's disease brain.

Authors:  Jae K Ryu; James G McLarnon
Journal:  J Cell Mol Med       Date:  2008-07-24       Impact factor: 5.310

View more
  50 in total

1.  The potential for salmon fibrin and thrombin to mitigate pain subsequent to cervical nerve root injury.

Authors:  Christine L Weisshaar; Jessamine P Winer; Benjamin B Guarino; Paul A Janmey; Beth A Winkelstein
Journal:  Biomaterials       Date:  2011-09-22       Impact factor: 12.479

Review 2.  The myeloid cells of the central nervous system parenchyma.

Authors:  Richard M Ransohoff; Astrid E Cardona
Journal:  Nature       Date:  2010-11-11       Impact factor: 49.962

3.  Combination therapy with VELCADE and tissue plasminogen activator is neuroprotective in aged rats after stroke and targets microRNA-146a and the toll-like receptor signaling pathway.

Authors:  Li Zhang; Michael Chopp; Xianshuang Liu; Hua Teng; Tao Tang; Haifa Kassis; Zheng Gang Zhang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-06-21       Impact factor: 8.311

4.  Alzheimer's disease peptide beta-amyloid interacts with fibrinogen and induces its oligomerization.

Authors:  Hyung Jin Ahn; Daria Zamolodchikov; Marta Cortes-Canteli; Erin H Norris; J Fraser Glickman; Sidney Strickland
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-22       Impact factor: 11.205

5.  Treatment of traumatic brain injury in rats with N-acetyl-seryl-aspartyl-lysyl-proline.

Authors:  Yanlu Zhang; Zheng Gang Zhang; Michael Chopp; Yuling Meng; Li Zhang; Asim Mahmood; Ye Xiong
Journal:  J Neurosurg       Date:  2016-05-20       Impact factor: 5.115

Review 6.  Protein biomarkers of epileptogenicity after traumatic brain injury.

Authors:  Denes V Agoston; Alaa Kamnaksh
Journal:  Neurobiol Dis       Date:  2018-07-17       Impact factor: 5.996

7.  Fibrinogen in the Nervous System: Glia Beware.

Authors:  Erin H Norris; Sidney Strickland
Journal:  Neuron       Date:  2017-12-06       Impact factor: 17.173

Review 8.  The Neuro-Immune-Regulators (NIREGs) Promote Tissue Resilience; a Vital Component of the Host's Defense Strategy against Neuroinflammation.

Authors:  Yosra Bedoui; Jim W Neal; Philippe Gasque
Journal:  J Neuroimmune Pharmacol       Date:  2018-06-16       Impact factor: 4.147

Review 9.  Effects of integrins and integrin αvβ3 inhibitor on angiogenesis in cerebral ischemic stroke.

Authors:  Jia-Jia Bi; Li Yi
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-06-18

Review 10.  Role of platelets in neuroinflammation: a wide-angle perspective.

Authors:  Lawrence L Horstman; Wenche Jy; Yeon S Ahn; Robert Zivadinov; Amir H Maghzi; Masoud Etemadifar; J Steven Alexander; Alireza Minagar
Journal:  J Neuroinflammation       Date:  2010-02-03       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.